Krystal Biotech

Krystal Biotech

World Rank (Aug-2026)
2236
Market Cap (Aug-2026)
9.835 Billion USD
World Rank (Jan-05-2024)
3,986
Market Cap (Jan-05-2024)
3.388 Billion USD
World Rank (Jul-30-2023)
4,110
Market Cap (Jul-30-2023)
3.259 Billion USD
World Rank (Jan-07-2022)
7,197
Market Cap (Jan-07-2022)
1.599 Billion USD
World Rank (Jan-01-2021)
7,295
Market Cap (Jan-01-2021)
1.182 Billion USD
Headquarters Country
USA
Top Technology Companies in USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
KRYS
Employee Count
119
Employee Count as of Date
As on 2021
Headquarters City/State
Pennsylvania
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
389 Million USD
Annual Operating Income in USD
161 Million USD
Annual Net Income in USD
205 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
1,334 Million USD
Total Liabilities in USD
114 Million USD
Total Equity in USD
1,220 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Technology
HealthCare Products
Company Website
KRYSTAL BIOTECH
Yahoo
Yahoo @ Nasdaq
Company Profile
Krystal Biotech is a Clinical Stage Gene Therapy company. It initially developing topical and intradermal "off-the-shelf" novel therapies for rare and orphan dermatological indications and expanding the use of pioneering STAR-D technology to target and treat other skin conditions as well. The headquarters is in USA.
IPO Year
2017
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share